Association Between Xrcc3 Thr241met Polymorphism and Nasopharyngeal Carcinoma Risk: Evidence from A Large-Scale Case-Control Study and A Meta-Analysis

Qian Cui,Xiao-Yu Zuo,Yi-Fan Lian,Qi-Sheng Feng,Yun-Fei Xia,Cai-Yun He,Li-Zhen Chen,Wei-Hua Jia,Hai-Qiang Mai,Yi-Xin Zeng,Jin-Xin Bei
DOI: https://doi.org/10.1007/s13277-016-5300-y
2016-01-01
Tumor Biology
Abstract:The X-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism (rs861539, C > T) has drawn wide attentions as its association with cancer risk and its involvement in DNA repair. Several studies have attempted to link rs861539 to nasopharyngeal cancer (NPC) risk; however, the sample sizes of these studies are small and the results are controversial. To investigate the relationship of rs861539 and NPC susceptibility, we conducted a large-scale case-control study involving 4001 NPC cases and 2967 controls of southern Chinese. Logistic regression analysis revealed significant association for rs861539 and NPC risk under the recessive model (TT vs. CT + CC) with adjustment of age and gender (odds ratio, OR = 2.72; 95 % CI 1.10-6.72; P = 0.03). Further, meta-analysis involving 4457 NPC cases and 4132 controls from four studies showed consistent association of TTcarriers and NPC risk (OR = 3.12; 95% CI 1.58-6.13; P = 0.001). Taken together, our findings based on large-scale sample size suggested rs861539 at XRCC3 to be associated with NPC risk through recessive model.
What problem does this paper attempt to address?